First National Bank of Omaha’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.52K Hold
15,225
﹤0.01% 497
2025
Q4
$9.78K Buy
+15,225
New +$11.7K ﹤0.01% 503

Other funds holding CTSO

First National Bank of Omaha's CTSO Position: Q1 2026 in Review

First National Bank of Omaha held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 15,225 shares worth $8.52K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

First National Bank of Omaha first reported a position in CTSO in Q4 2025 and has held it in 2 quarters since. The position peaked at $9.78K in Q4 2025. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • First National Bank of Omaha held 15,225 shares of Cytosorbents Corp worth $8.52K as of Q1 2026.
  • First National Bank of Omaha left its Cytosorbents Corp share count unchanged in Q1 2026.
  • Cytosorbents Corp made up ﹤0.01% of First National Bank of Omaha's portfolio in Q1 2026, its #497 holding.
  • First National Bank of Omaha first reported a position in Cytosorbents Corp in Q4 2025 and has held it in 2 quarters since.
  • First National Bank of Omaha's Cytosorbents Corp position peaked at $9.78K in Q4 2025.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on First National Bank of Omaha's 13F filing for Q1 2026, filed 11 May 2026.